Susquehanna International Group’s Apyx Medical APYX Stock Holding History

Susquehanna International Group’s Portfolio APYX Stock Details APYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-45,100	Closed	-$96.5K	–	12269
2025 Q3	$96.5K	Buy	45,100 +32,200	+250%	+$68.2K	﹤0.01%	11587
2025 Q2	$29K	Buy	+12,900	New	+$18.2K	﹤0.01%	12257
2023 Q3	–	Sell	-101,300	Closed	-$510K	–	11963
2023 Q2	$510K	Buy	+101,300	New	+$513K	﹤0.01%	8264
2022 Q4	–	Sell	-14,700	Closed	-$66K	–	12330
2022 Q3	$66K	Sell	14,700 -6,000	-29%	-$43K	﹤0.01%	12016
2022 Q2	$121K	Buy	+20,700	New	+$106K	﹤0.01%	11268
2019 Q3	–	Sell	-11,200	Closed	-$75K	–	10117
2019 Q2	$75K	Buy	+11,200	New	+$60.9K	﹤0.01%	9719

Other funds holding APYX

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

ACM

Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

SBCM

Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return

EIM

Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

HKAM

Horizon Kinetics Asset Management New York $9.23B AUM 27.52% 1-Year Est. Return

SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return

Susquehanna International Group's APYX Position: Q1 2026 in Review

Susquehanna International Group increased its Apyx Medical (APYX) stake by 33% in Q1 2026, buying an estimated $246K and bringing the position to 267,561 shares worth $987K. The position accounts for ﹤0.01% of the portfolio, ranked #7918.

Susquehanna International Group first reported a position in APYX in Q1 2016 and has held it in 23 quarters since. The position peaked at $1.3M in Q1 2019. 67 funds tracked by Wall St. Rank hold APYX as of Q1 2026.

Susquehanna International Group held 267,561 shares of Apyx Medical worth $987K as of Q1 2026.
Susquehanna International Group bought 65,910 Apyx Medical shares in Q1 2026, an estimated $246K.
Apyx Medical made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #7918 holding.
Susquehanna International Group first reported a position in Apyx Medical in Q1 2016 and has held it in 23 quarters since.
Susquehanna International Group's Apyx Medical position peaked at $1.3M in Q1 2019.
67 funds tracked by Wall St. Rank held Apyx Medical as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.